Endocrine therapy of prostate cancer: optimal form and timing.
Labrie
F
F
Laval University Medical Center, Québec City, Canada.
D000311:Adrenal Glands / Q000378:metabolism; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000378:metabolism; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D008297:Male; D011300:Preoperative Care; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D013737:Testis / Q000378:metabolism; D013997:Time Factors
D000726:Androgen Antagonists; D000728:Androgens; D007987:Gonadotropin-Releasing Hormone